Among the 3 prospective studies that have examined the association between copeptin and the risk of incident diabetes, The Malmö Diet and Cancer (MDC) Study showed an association independent of fasting insulin and blood glucose (14), whereas the FINRISK97 Study showed no independent association between copeptin and diabetes after adjustment for metabolic risk factors (16). This evidence concerns the gene AVP and cancer.